In the context of cancer treatment, G-CSF is primarily used to manage neutropenia, a condition characterized by an abnormally low number of neutrophils. Neutropenia is a common side effect of chemotherapy and can significantly increase the risk of infections. By administering G-CSF, healthcare professionals can reduce the incidence of febrile neutropenia, allowing patients to continue their chemotherapy regimen with fewer interruptions.
